United States Micro-RNA Sequencing and Assay Market was valued at USD 0.8 Billion in 2022 and is projected to reach USD 2.1 Billion by 2030, growing at a CAGR of 14.3% from 2024 to 2030.
The US Micro-RNA Sequencing and Assay Market is rapidly expanding, fueled by the increasing demand for advanced diagnostic and therapeutic techniques. This market plays a crucial role in the analysis of micro-RNAs (miRNAs), which are essential for regulating gene expression and have emerged as significant biomarkers in various diseases, including cancer, cardiovascular conditions, and neurological disorders.
Micro-RNA sequencing and assay technologies have gained significant attention from industries due to their ability to provide high-throughput, precise, and cost-effective solutions for miRNA profiling. As the demand for personalized medicine and precision therapies grows, the need for these tools to analyze and profile miRNA has become essential in clinical research and diagnostics. Industries such as pharmaceuticals, biotechnology, and clinical research organizations (CROs) are heavily investing in miRNA sequencing technologies to develop next-generation therapies and diagnostic tools.
Several factors contribute to the surge in demand for the Micro-RNA Sequencing and Assay Market. Key drivers include the growing prevalence of chronic diseases, technological advancements in sequencing platforms, and the increasing recognition of miRNAs as biomarkers for early disease detection. Additionally, the availability of high-performance sequencing platforms, such as Illumina and PacBio, is making it easier for industries to adopt miRNA sequencing and assay techniques for various applications, including biomarker discovery, drug development, and gene expression analysis.
Another essential aspect driving market growth is the increasing focus on non-invasive diagnostic methods. miRNA profiles, often found in bodily fluids such as blood and saliva, provide a unique opportunity for liquid biopsy applications. This not only improves the accuracy of diagnostics but also reduces the need for more invasive procedures, benefiting patients and clinicians alike.
The US Micro-RNA Sequencing and Assay Market is expected to continue its growth trajectory, with continuous innovations and advancements in sequencing technologies, as well as expanding demand from industries looking to harness miRNA analysis for better healthcare outcomes. As researchers uncover new potential applications of miRNAs, the market will likely see even broader industry involvement, paving the way for more transformative solutions in personalized medicine and diagnostics.
Get an In-Depth Research Analysis of the US Micro-RNA Sequencing and Assay Market Size And Forecast [2025-2032]
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Micro-RNA Sequencing and Assay Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Micro-RNA Sequencing and Assay Market
Microarray-Based Technology
Sequencing-Based Technology
Oncology
Cardiology
Neurology
Infectious Diseases
Other Applications
Consumables
Instruments
Software & Services
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Hospitals & Diagnostic Laboratories
Blood
Tissues
Urine
Saliva
Other Sample Types
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Micro-RNA Sequencing and Assay Market Research Analysis
1. Introduction of the US Micro-RNA Sequencing and Assay Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Micro-RNA Sequencing and Assay Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Micro-RNA Sequencing and Assay Market, By Type
6. US Micro-RNA Sequencing and Assay Market, By Application
7. US Micro-RNA Sequencing and Assay Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Micro-RNA Sequencing and Assay Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/